Rukaiyya T. Girase

Optimizing Bedaquiline for cardiotoxicity by structure based virtual screening, DFT analysis and molecular dynamic simulation studies to identify selective MDR-TB inhibitors

Iqrar Ahmad, Harsha Jadhav, Yashodeep Shinde et al. · In Silico Pharmacology · 2021 · 68 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Synthesis, Molecular Modeling Study, and Quantum-Chemical-Based Investigations of Isoindoline-1,3-diones as Antimycobacterial Agents

Iqrar Ahmad, Rahul Pawara, Rukaiyya T. Girase et al. · ACS Omega · 2022 · 50 citations · Full text

Pharmacy, Chemistry, Medicinal Chemistry +15

Optimizing cardio, hepato and phospholipidosis toxicity of the Bedaquiline by chemoinformatics and molecular modelling approach

Rukaiyya T. Girase, Iqrar Ahmad, Rahul Pawara et al. · SAR and QSAR in environmental research · 2022 · 33 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Bioisosteric modification of Linezolid identified the potential <i>M. tuberculosis</i> protein synthesis inhibitors to overcome the myelosuppression and serotonergic toxicity associated with Linezolid in the treatment of the multi-drug resistance tuberculosis (MDR-TB)

Rukaiyya T. Girase, Iqrar Ahmad, Harun Patel · Journal of Biomolecular Structure and Dynamics · 2023 · 19 citations

Pharmacy, Medicinal Chemistry, Pharmacology +14

Design and Synthesis of the Linezolid Bioisosteres to Resolve the Serotonergic Toxicity Associated with Linezolid

Rukaiyya T. Girase, Iqrar Ahmad, Jong‐Min Oh et al. · ACS Medicinal Chemistry Letters · 2024 · 12 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13